Application 021316
- Type
- NDA
- Sponsor
- COVIS PHARMA BV
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALTOPREV | LOVASTATIN | TABLET, EXTENDED RELEASE;ORAL | 10MG | No | No |
| 002 | ALTOPREV | LOVASTATIN | TABLET, EXTENDED RELEASE;ORAL | 20MG | Yes | No |
| 003 | ALTOPREV | LOVASTATIN | TABLET, EXTENDED RELEASE;ORAL | 40MG | Yes | No |
| 004 | ALTOPREV | LOVASTATIN | TABLET, EXTENDED RELEASE;ORAL | 60MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021316-001 | ALTOPREV | LOVASTATIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | ||
| N021316-002 | ALTOPREV | LOVASTATIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | |
| N021316-003 | ALTOPREV | LOVASTATIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | |
| N021316-004 | ALTOPREV | LOVASTATIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-06-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-06-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-06-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-06-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021316-001 | ALTOPREV | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2002-06-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021316-002 | ALTOPREV | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021316-003 | ALTOPREV | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-06-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021316-004 | ALTOPREV | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-06-26 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovastatin | LOVASTATIN | A-S Medication Solutions | dd7a223e-7fc5-4eb0-9bd7-2f9a2d6b4173 | 2025-10-10 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | A-S Medication Solutions | bfb889a4-5751-4706-9fa7-f48672c1bc08 | 2025-10-10 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | 220a9b3c-c583-49e3-8bf0-d0c97dc9b829 | 2025-04-01 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | c37206ae-52f1-4192-9ab9-3044247cf58d | 2025-03-13 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | ac86821f-d741-4ab1-bd03-ce8797dd4f34 | 2025-03-12 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | 70e2bf86-4a78-4dfb-b6b1-8eb95f63684d | 2025-03-06 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | eea93a4b-f804-4b9c-aabf-e906f03c1e80 | 2025-02-28 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 2eff3e5e-8746-048e-e063-6294a90a38c4 | 2025-02-25 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 2eeb34ac-f973-e7d9-e063-6294a90a076e | 2025-02-24 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | NuCare Pharmaceuticals, Inc. | 50217921-97a7-6ff2-e054-00144ff88e88 | 2025-02-04 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Carlsbad Technology, Inc. | 0a680e13-0356-4e08-a7fe-78b96ba51b9d | 2025-01-07 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | A-S Medication Solutions | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 2024-12-12 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | A-S Medication Solutions | 02aae38d-ee9d-4c09-a155-b69f221ed3e9 | 2024-10-15 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | c871a6a7-67a4-4ac1-b102-3f1604625c7d | 2024-09-12 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | NuCare Pharmaceuticals, Inc. | 415c2698-7787-49f8-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | NuCare Pharmaceuticals, Inc. | 4444573e-9df1-01e6-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | 8d8199ca-df39-4eb8-a905-dee3ab7e2973 | 2024-08-14 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | 5684ceb8-a5b2-4fb4-92be-14aabcea3871 | 2024-08-09 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | ad905651-6e3a-4140-aa37-d91e5f37c0f0 | 2024-08-08 | Warnings, Adverse reactions | LOVASTATIN |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | a623c1da-e94e-41be-900c-9e74376d36c8 | 2024-08-08 | Warnings, Adverse reactions | LOVASTATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70515-628 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-628 | Altoprev | lovastatin | Covis Pharma US, Inc | NDA | Current |
| 70515-628 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-628 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-629 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-629 | Altoprev | lovastatin | Covis Pharma US, Inc | NDA | Current |
| 70515-629 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-629 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-630 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-630 | Altoprev | lovastatin | Covis Pharma US, Inc | NDA | Current |
| 70515-630 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
| 70515-630 | Altoprev | lovastatin | Covis Pharma | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77836 | SUPPL | 2024-03-15 |
| 64717 | SUPPL | 2020-09-29 |
| 64701 | SUPPL | 2020-09-28 |
| 52805 | SUPPL | 2018-03-02 |
| 52795 | SUPPL | 2018-03-02 |
| 49279 | SUPPL | 2017-08-08 |
| 49269 | SUPPL | 2017-08-08 |
| 36641 | SUPPL | 2014-05-02 |
| 27462 | SUPPL | 2014-05-01 |
| 15171 | SUPPL | 2012-12-28 |
| 5010 | SUPPL | 2012-12-27 |
| 27461 | SUPPL | 2012-11-05 |
| 15172 | SUPPL | 2012-11-02 |
| 27460 | SUPPL | 2012-05-02 |
| 15170 | SUPPL | 2012-04-27 |
| 42094 | SUPPL | 2007-07-09 |
| 42095 | SUPPL | 2007-04-30 |
| 5009 | SUPPL | 2007-02-12 |
| 36640 | SUPPL | 2004-07-21 |
| 27459 | SUPPL | 2004-07-21 |
| 5006 | SUPPL | 2004-05-28 |
| 36639 | SUPPL | 2003-09-30 |
| 5008 | SUPPL | 2003-09-30 |
| 5007 | SUPPL | 2003-08-28 |
| 21594 | ORIG | 2003-04-30 |
| 15169 | SUPPL | 2002-09-11 |
| 36638 | ORIG | 2002-06-26 |
| 5005 | ORIG | 2002-06-26 |